首页 > 市场调查报告书 > 医疗设备

医学影像诊断癌症个人化医学分子呈像/呈影剂核子医学

市场调查报告书

商品编码

1469865

全球放射治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Radiotheranostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 236 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球放射治疗市场需求预计将从 2023 年的 80.3 亿美元增至 2032 年近 239.7 亿美元，2024-2032 年研究期间复合年增长率为 12.92%。

放射治疗学是一个新兴领域，它将诊断影像和标靶放射治疗结合起来进行个人化癌症治疗。它涉及放射性药物的开发和使用，这些药物可以透过对肿瘤细胞进行治疗剂量的辐射来诊断和治疗癌症，同时不伤害健康组织。这种方法针对癌细胞表达的特定分子标记或受体，实现肿瘤的精确定位和治疗，同时透过影像学方法（包括正子断层扫描（PET）或单光子发射电脑断层扫描（SPECT））监测治疗反应。

市场动态

全球癌症盛行率的不断上升刺激了对更有效和个人化治疗方案的需求，导致人们对放射治疗方法越来越感兴趣。放射治疗学将治疗和诊断功能结合在单一试剂中，为标靶癌症治疗和用于治疗计划和监测的精确成像提供了一种有前途的解决方案。此外，放射性药物和影像技术的进步提高了放射治疗程序的有效性和安全性，鼓励医疗保健提供者和患者采用它们。此外，製药公司和学术机构对研发的投资不断增加，推动了新型放射治疗剂和影像模式的创新和商业化。

此外，旨在促进精准医疗和改善癌症护理的有利政府措施和监管支持进一步刺激了放射治疗市场的成长。此外，医疗保健从业者和患者对放射治疗在改善治疗结果和减少副作用方面的好处的认识不断提高，这有助于市场扩张。然而，不断变化的监管环境和定价压力可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球放射治疗市场的每个细分市场进行了包容性评估。放射治疗产业的成长和趋势为这项研究提供了整体方法。

市场区隔

放射治疗市场报告的这一部分提供了国家和区域层级细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人口统计数据以及即将到来的机会。

透过放射性同位素

碘131
碘123
镓68
镥177
18F 配Y-90
其他的

依方法

标靶治疗
针对性诊断

按申请

肿瘤学（甲状腺癌、神经内分泌肿瘤、肝细胞癌、摄护腺癌、其他）
非肿瘤学（神经系统疾病、关节炎、其他）

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲放射治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。放射治疗市场的主要参与者包括 Progenics Pharmaceuticals, Inc. (Lantheus)、Telix Pharmaceuticals Limited、ITM Radiopharma、Life Molecular Imaging.、RadioMedix、IsoTherapeutics Group, LLC、Q BioMed Inc.、Nordic Nanovector ASA、Novartis AG。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：放射治疗公司的竞争格局

放射治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Progenics Pharmaceuticals Inc. (Lantheus)

公司简介
公司收入
产品
最近的发展

Telix Pharmaceuticals Limited

公司简介
公司收入
产品
最近的发展

ITM Radiopharma

公司简介
公司收入
产品
最近的发展

Life Molecular Imaging.

公司简介
公司收入
产品
最近的发展

RadioMedix

公司简介
公司收入
产品
最近的发展

IsoTherapeutics Group LLC

公司简介
公司收入
产品
最近的发展

Q BioMed Inc.

公司简介
公司收入
产品
最近的发展

Nordic Nanovector ASA

公司简介
公司收入
产品
最近的发展

Novartis AG

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114260

The global demand for Radiotheranostics Market is presumed to reach the market size of nearly USD 23.97 Billion by 2032 from USD 8.03 Billion in 2023 with a CAGR of 12.92% under the study period 2024 - 2032.

Radiotheranostics is an emerging field that combines diagnostic imaging and targeted radiotherapy for personalized cancer treatment. It involves the development and use of radiopharmaceuticals that can both diagnose and treat cancer by administering therapeutic doses of radiation to tumor cells while sparing healthy tissue. This approach targets specific molecular markers or receptors expressed by cancer cells, enabling precise localization and treatment of tumors while monitoring treatment response through imaging methods, including positron emission tomography (PET) or single-photon emission computed tomography (SPECT).

MARKET DYNAMICS

The increasing prevalence of cancer worldwide has spurred the demand for more effective and personalized treatment options, leading to a growing interest in radiotheranostic approaches. Radiotheranostics, which combines therapeutic and diagnostic capabilities in a single agent, offers a promising solution for targeted cancer therapy and accurate imaging for treatment planning and monitoring. Furthermore, advancements in radiopharmaceuticals and imaging technologies have enhanced the efficacy and safety of radiotheranostic procedures, encouraging their adoption by healthcare providers and patients. Additionally, the rising investments in research and development by pharmaceutical companies and academic institutions fuel the innovation and commercialization of novel radiotheranostic agents and imaging modalities.

Moreover, favorable government initiatives and regulatory support aimed at promoting precision medicine and improving cancer care are further stimulating the growth of the radiotheranostics market. Additionally, the increasing awareness among healthcare practitioners and patients about the benefits of radiotheranostics in improving treatment outcomes and reducing side effects contributes to market expansion. However, the evolving regulatory landscape and pricing pressures may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of radiotheranostics. The growth and trends of radiotheranostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the radiotheranostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Radioisotope

Iodine-131
Iodine-123
Gallium-68
Lutetium-177
18F With Y-90
Others

By Approach

Targeted Therapeutic
Targeted Diagnostic

By Application

Oncology (Thyroid Cancer, Neuroendocrine Tumors, Hepatocellular Carcinoma, Prostate Cancer, Others)
Non-Oncology (Neurological Disorders, Arthritis, Others)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Radiotheranostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Radiotheranostics market include Progenics Pharmaceuticals, Inc. (Lantheus), Telix Pharmaceuticals Limited, ITM Radiopharma, Life Molecular Imaging., RadioMedix, IsoTherapeutics Group, LLC, Q BioMed Inc., Nordic Nanovector ASA, Novartis AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. RADIOTHERANOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Radioisotope
- 3.7.2 Market Attractiveness Analysis By Approach
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL RADIOTHERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE

5.1. Overview By Radioisotope
5.2. Historical and Forecast Data
5.3. Analysis By Radioisotope
5.4. Iodine-131 Historic and Forecast Sales By Regions
5.5. Iodine-123 Historic and Forecast Sales By Regions
5.6. Gallium-68 Historic and Forecast Sales By Regions
5.7. Lutetium-177 Historic and Forecast Sales By Regions
5.8. 18F with Y-90 Historic and Forecast Sales By Regions
5.9. Others Historic and Forecast Sales By Regions

6. GLOBAL RADIOTHERANOSTICS MARKET ANALYSIS BY APPROACH

6.1. Overview By Approach
6.2. Historical and Forecast Data
6.3. Analysis By Approach
6.4. Targeted Therapeutic Historic and Forecast Sales By Regions
6.5. Targeted Diagnostic Historic and Forecast Sales By Regions

7. GLOBAL RADIOTHERANOSTICS MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data
7.3. Analysis By Application
7.4. Oncology (Thyroid Cancer, Neuroendocrine Tumors, Hepatocellular Carcinoma, Prostate Cancer, Others) Historic and Forecast Sales By Regions
7.5. Non-oncology (Neurological Disorders, Arthritis, Others) Historic and Forecast Sales By Regions

8. GLOBAL RADIOTHERANOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE RADIOTHERANOSTICS COMPANIES

9.1. Radiotheranostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF RADIOTHERANOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Progenics Pharmaceuticals Inc. (Lantheus)
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Telix Pharmaceuticals Limited
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. ITM Radiopharma
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Life Molecular Imaging.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. RadioMedix
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. IsoTherapeutics Group LLC
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Q BioMed Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Nordic Nanovector ASA
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Novartis AG
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Radioisotope (USD MN)
Iodine-131 Market Sales By Geography (USD MN)
Iodine-123 Market Sales By Geography (USD MN)
Gallium-68 Market Sales By Geography (USD MN)
Lutetium-177 Market Sales By Geography (USD MN)
18F with Y-90 Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Approach (USD MN)
Targeted Therapeutic Market Sales By Geography (USD MN)
Targeted Diagnostic Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Oncology (Thyroid Cancer, Neuroendocrine Tumors, Hepatocellular Carcinoma, Prostate Cancer, Others) Market Sales By Geography (USD MN)
Non-oncology (Neurological Disorders, Arthritis, Others) Market Sales By Geography (USD MN)
Global Radiotheranostics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Radiotheranostics Report
Market Research Process
Market Research Methodology
Global Radiotheranostics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Radioisotope
Market Attractiveness Analysis By Approach
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Radioisotope (USD MN)
Iodine-131 Market Sales By Geography (USD MN)
Iodine-123 Market Sales By Geography (USD MN)
Gallium-68 Market Sales By Geography (USD MN)
Lutetium-177 Market Sales By Geography (USD MN)
18F with Y-90 Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By Approach (USD MN)
Targeted Therapeutic Market Sales By Geography (USD MN)
Targeted Diagnostic Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Oncology (Thyroid Cancer, Neuroendocrine Tumors, Hepatocellular Carcinoma, Prostate Cancer, Others) Market Sales By Geography (USD MN)
Non-oncology (Neurological Disorders, Arthritis, Others) Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis